Concepedia

A. John Diamonti

AJ

Statistics

Publications

7

Citations

1.7K

H-Index

7

Active since

1994

Affiliations

Harvard University(Current)

Beth Israel Deaconess Medical Center

Beth Israel Deaconess Hospital

A. John Diamonti is an author at Harvard University specializing in cell signaling, signal transduction, and medicine.

Top concepts

Publications per year

1994–2002

7

Publications

7

Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2

Miikka Vikkula, Laurence M. Boon, Kermit L. Carraway et al. · Cell · 1996 · 803 citations · Full text

, , +10

The erbB3 gene product is a receptor for heregulin.

Kermit L. Carraway, Mark X. Sliwkowski, Robert W. Akita et al. · Journal of Biological Chemistry · 1994 · 360 citations · Full text

, , +15

Heregulin Stimulates Mitogenesis and Phosphatidylinositol 3-Kinase in Mouse Fibroblasts Transfected with erbB2/neu and erbB3

Kermit L. Carraway, Stephen P. Soltoff, A. John Diamonti et al. · Journal of Biological Chemistry · 1995 · 138 citations · Full text

Ligand Discrimination in Signaling through an ErbB4 Receptor Homodimer

Colleen Sweeney, Cary Lai, David J. Riese et al. · Journal of Biological Chemistry · 2000 · 131 citations · Full text

An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels

A. John Diamonti, Pamela M. Guy, Caryn Ivanof et al. · Proceedings of the National Academy of Sciences · 2002 · 124 citations · Full text

1–5 of 7